One-Year Results of a Trial Comparing 2 Doses of Intravitreal Ziv-aflibercept versus Bevacizumab for Treatment of Diabetic Macular Edema.

Jabbarpoor Bonyadi, Mohammad Hossein; Baghi, Ahmadreza; Ramezani, Alireza; Yaseri, Mehdi; Soheilian, Masoud

Jabbarpoor Bonyadi, Mohammad Hossein; Baghi, Ahmadreza; Ramezani, Alireza; Yaseri, Mehdi; Soheilian, Masoud.

Afiliação

Jabbarpoor Bonyadi MH; Ophthalmic Research Center, Labbafinejad Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Baghi A; Ophthalmic Research Center, Labbafinejad Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ramezani A; Ophthalmic Research Center, Labbafinejad Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Negah Eye Hospital, Tehran, Iran; Torfe Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Yaseri M; Ophthalmic Research Center, Labbafinejad Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Soheilian M; Ophthalmic Research Center, Labbafinejad Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Negah Eye Hospital, Tehran, Iran. Electronic address: masoud_soheilian@yahoo.com.

Ophthalmol Retina ; 2(5): 428-440, 2018 05.

Article em En | MEDLINE | ID: mdl-31047323

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ophthalmol Retina Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Irã País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google